ClinicalTrials.gg
Not yet recruitingNCT07666503RIRRUpdated Jun 24, 2026

Assessment of the Reproducibility of the Recruitment-to-inflation Ratio (R/I Ratio) Measurement in Patients With Acute Respiratory Distress Syndrome

An observational study in Acute Respiratory Distress Syndrome (ARDS), sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 33 studies in Respiratory Distress Syndrome by Assistance Publique - Hôpitaux de Paris — 16 open to participants now, 16 under way, 2 of them phase 3. Respiratory Distress Syndrome · Assistance Publique - Hôpitaux de Paris.

Planned enrollment
6th of 11
80 · median 80
Started
2026
with 3 others
Observational
11 of 33
6 open now
Primary completion
2027-06
later than 7 of 15 live
Registered
33rd of 33
by date

Among the 33 studies in Respiratory Distress Syndrome by Assistance Publique - Hôpitaux de Paris, this one is the 6th largest by planned enrollment of the 11 observational ones that give a count, is one of 4 that started in 2026, is one of 11 observational ones, reaches primary completion later than 7 of the 15 other live ones, and was the 33rd registered.

Respiratory Distress Syndrome

1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.

Browse Respiratory Distress Syndrome studies →

Open to participants now

16 of the 33 studies in Respiratory Distress Syndrome by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

10 more — sign in →

By country, each count listing its studies:

All 16 open studies →

Where they have run

Who these studies take

Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Respiratory Distress Syndrome by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

Acute respiratory distress syndrome (ARDS) is a severe lung condition that often requires invasive mechanical ventilation in the intensive care unit. In these patients, setting the ventilator appropriately is essential to improve oxygenation while limiting ventilator-induced lung injury. One important ventilator setting is positive end-expiratory pressure (PEEP), which helps keep the lungs open. However, the optimal PEEP level may vary from one patient to another.

The recruitment-to-inflation ratio (R/I ratio) is a bedside measurement used to estimate the potential for lung recruitment during a decrease in PEEP. It compares the compliance of the lung volume recruited by PEEP with the compliance of the already aerated lung. A higher R/I ratio suggests that increasing PEEP is more likely to reopen collapsed lung units, whereas a lower R/I ratio suggests limited recruitability and a higher likelihood that additional pressure would mainly distend lung areas that are already open. In clinical practice, the R/I ratio is increasingly used to guide PEEP adjustment, with the aim of improving recruitment and oxygenation while avoiding unnecessary increases in airway pressure. However, although the R/I ratio is used in routine care, there are currently no data demonstrating that this measurement is reproducible when repeated in the same patient under similar conditions.

The hypothesis of this study is that the R/I ratio is reproducible when measured twice in the same patient under stable conditions, including no significant changes in ventilator settings, hemodynamic status, or ongoing treatments.

This prospective, multicenter, non-interventional study will include adult ICU patients with ARDS who are receiving invasive mechanical ventilation, deep sedation, and assist-control ventilation. For each patient, airway opening pressure will be assessed, and the R/I ratio will be measured twice on the same day by a trained clinician, between 20 and 120 minutes apart, without changes in ventilator settings or treatments likely to influence the measurement.

The main objective is to evaluate the within-patient reproducibility of the R/I ratio. Secondary objectives include describing changes in airway opening pressure and R/I ratio over time, assessing the reproducibility of expired tidal volume during the maneuvers, and evaluating the clinical tolerance of these ventilatory measurements.

The study will include 80 patients across 4 French intensive care units. No additional intervention outside routine care will be performed. Clinical, ventilatory, and biological data already collected as part of usual care will be recorded.

Read the detailed description

Acute respiratory distress syndrome (ARDS) is a severe form of acute respiratory failure requiring invasive mechanical ventilation. Lung-protective ventilation strategies, including the adjustment of positive end-expiratory pressure (PEEP), are central to management but remain challenging due to inter-individual variability in lung recruitability and mechanics.

The recruitment-to-inflation ratio (R/I) is a bedside physiological measurement used to estimate the potential for lung recruitment following a change in PEEP. It reflects the proportion of volume gain attributable to recruitment of previously non-aerated lung regions, as opposed to inflation of already aerated lung ("baby lung"). In clinical practice, this parameter is used in some centers to help guide PEEP selection, with the aim of avoiding unnecessary PEEP increases in patients with low recruitability, which may expose them to lung overdistension. In parallel, the measurement of airway opening pressure (AOP) allows identification of airway closure and may help optimize ventilator settings.

Although R/I ratio and AOP measurements are increasingly used in routine care, no data are currently available regarding the reproducibility of the R/I ratio when measured repeatedly in the same patient under stable conditions. Assessing this reproducibility is essential to determine whether observed variations reflect true physiological changes or measurement variability.

This is a prospective, multicenter, non-interventional study conducted in four French intensive care units where R/I ratio and AOP measurements are part of routine clinical practice. Adult patients with ARDS receiving invasive mechanical ventilation under deep sedation and assist-control mode will be included.

For each patient, AOP will be assessed using a standardized low-flow inflation maneuver. The R/I ratio will be measured using a standardized PEEP step maneuver, consisting of a decrease in PEEP from a high level (typically 15 cmH₂O) to a lower level (typically 5 cmH₂O or adjusted to AOP when present), with measurement of the resulting expired volume. The recruited volume is calculated as the difference between measured expired volume and predicted volume based on compliance at low PEEP, allowing computation of the R/I ratio. These procedures follow standardized methods routinely used in participating centers.

Two R/I measurements (T1 and T2) will be performed in each patient on the same day, 20 to 120 minutes apart, by the same trained clinician. Measurements will be conducted under strictly stable conditions, including no significant changes in ventilator settings, hemodynamic status, patient position, or ongoing treatments. Predefined stability criteria include limited variation in vasopressor dose, arterial pressure, heart rate, oxygenation, and ventilator parameters.

Clinical, ventilatory, and biological data routinely collected as part of standard care will be recorded. Data will be entered into a secure electronic case report form (eCRF) using REDCap. Data collection is prospective, with pseudonymization of patient identifiers.

Data quality will be ensured through predefined data entry checks in the eCRF, including range checks and consistency checks across variables. Source data verification may be performed by comparing eCRF entries with medical records when necessary. Investigators involved in the study are trained in both the measurement techniques and data collection procedures.

The primary objective is to assess intra-patient reproducibility of the R/I ratio. Reproducibility will be evaluated using an intraclass correlation coefficient (ICC, two-way mixed-effects model, absolute agreement). Secondary analyses include assessment of absolute and relative differences between measurements, reproducibility of expired tidal volume during maneuvers, longitudinal evolution of R/I and AOP during ICU stay, and clinical tolerance of the procedures.

The sample size is based on the precision of the ICC estimate. A total of 61 patients are required to estimate an ICC of 0.90 with a precision of 10%. To account for potential missing or non-analyzable data, 80 patients will be included.

Missing data will not be imputed and will be described. Analyses will be performed on available data under conditions where measurement validity criteria are met.

Statistical analyses will include descriptive statistics and appropriate comparative tests depending on data distribution. Reproducibility will be assessed using ICC, and agreement between measurements will also be explored using absolute and relative differences.

This study does not involve any intervention beyond routine care. The results are expected to provide important information on the reliability of R/I measurement and support its appropriate use in clinical practice.

03

Conditions studied

  • Acute Respiratory Distress Syndrome (ARDS)

Keywords

  • Mechanical Ventilation
  • Positive End-Expiratory Pressure
  • Lung Recruitment
  • Lung Recruitability
  • Respiratory Mechanics
  • Airway Opening Pressure
  • Reproducibility of Results
  • Intraclass Correlation Coefficient
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients admitted to intensive care units in participating centers for acute respiratory distress syndrome and requiring invasive mechanical ventilation will be screened for inclusion. The study population will be drawn from routine clinical practice in four French academic intensive care units where airway opening pressure and recruitment-to-inflation ratio measurements are performed as part of standard care in selected patients with moderate to severe disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (age ≥ 18 years)
  • Patient hospitalized in the Intensive Care Unit (ICU) for acute respiratory distress syndrome (according to the Berlin definition), requiring invasive mechanical ventilation with deep sedation and controlled mechanical ventilation mode
  • Patient or next of kin informed about the study and not objecting to participation

Exclusion criteria

Exclusion Criteria:

  • Undrained pneumothorax or any to a transient increase in airway pressure
  • Known or suspected intracranial hypertension
  • Patient under legal protection (e.g., guardianship)
  • Not affiliated with a social security system
  • Presence of spontaneous respiratory effort
  • Presence of a leak in the ventilatory circuit
  • Hemodynamic instability (e.g., uncontrolled shock, increasing vasopressor requirement)
  • Uncontrolled severe hypoxemia
  • Undrained pneumothorax or any contraindication to a transient increase in airway pressure
  • Known or suspected intracranial hypertension
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Intraclass Correlation Coefficient of the Recruitment-to-Inflation Ratio (R/I)

    Intra-patient reproducibility of the recruitment-to-inflation ratio (R/I) assessed using an intraclass correlation coefficient (ICC, two-way mixed-effects model, absolute agreement) between two measurements (T1 and T2) performed under stable clinical conditions.

    Time frame: Same day as inclusion, between 20 and 120 minutes between the two measurements

Secondary outcomes

  1. Absolute and relative difference in recruitment-to-inflation ratio (R/I) between two measurements (T1 and T2)

    Absolute (ΔR/I) and relative (%) difference in the recruitment-to-inflation ratio (R/I) between two measurements (T1 and T2) performed under stable clinical conditions.

    Time frame: Same day as inclusion, between 20 and 120 minutes between the two measurements

  2. Intra-patient reproducibility and variability of expired tidal volume (Vte)

    Intra-patient reproducibility of expired tidal volume (Vte) assessed using an intraclass correlation coefficient (ICC, two-way mixed-effects model, absolute agreement), as well as absolute and relative (%) differences between two measurements (T1 and T2).

    Time frame: Same day as inclusion, between 20 and 120 minutes between the two measurements

  3. Longitudinal evolution of recruitment-to-inflation ratio (R/I)

    Temporal evolution of the recruitment-to-inflation ratio (R/I) and airway opening pressure (AOP) assessed using repeated measurements during the ICU stay

    Time frame: From inclusion up to ICU discharge (maximum 28 days)

  4. Longitudinal evolution of airway opening pressure (AOP)

    Temporal evolution of airway opening pressure (AOP) assessed using repeated measurements when available during the ICU stay

    Time frame: From inclusion until ICU discharge (up to 28 days)

  5. Incidence of adverse events during ventilatory measurement procedures

    Occurrence of adverse events during or immediately after R/I or AOP measurement procedures, including oxygen desaturation (≥5% decrease or SpO₂ ≤85%), hemodynamic instability requiring increased vasopressors, new or worsening arrhythmia, or premature interruption of the maneuver.

    Time frame: Periprocedural (from initiation to immediate completion of each R/I or AOP measurement procedure), assessed during the ICU stay (up to 28 days)

07

Study locations

4 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jun 2027, 12 months later.

Of 228 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 234 studies reached it within 24 months; a quarter within 12 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2026
First posted
Jun 24, 2026
StartEst.
Jun 30, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Jun 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07666503
Responsible party
Sponsor
First posted
Jun 24, 2026
Start date
Jun 30, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jun 24, 2026

Study contacts

Tai PHAM
Contact
tai.pham@aphp.fr
145217245 ext. +33
Nicolas BIARD
Contact
nicolasbiard.bl@gmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion